The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first rapid-acting insulin ...

In unusual circumstances with hypoglycemia and maximized dextrose delivery, the insulin infusion rate may need to be decreased. Hypokalemia Inadequate potassium replacement and ongoing potassium ...